Search and analyze individual stocks with comprehensive metrics
Medplus Health Services Ltd
Fundamental Score
Medplus Health Services Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of MEDPLUS across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Robust Profit Growth (43.26%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Consistent Growth Track Record (16.41% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Strong Profit Growth Track Record (131.42% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Strong Cash Generation (₹469.03 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Strong Institutional Confidence (FII+DII: 43.04%)
Observation: Significant professional investor participation indicates quality recognition.
Analysis: High institutional holding often signals thorough due diligence and quality business fundamentals.
Risk Factors
6 factors identified
Below-Average Return on Equity (8.80%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Premium Valuation Risk (P/E: 49.79x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
Weak Earnings Growth (-35.35% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.
High Share Pledging Risk (59.34%)
Observation: Significant promoter share pledging creates potential overhang.
Analysis: High pledging levels may create selling pressure during market downturns or margin calls.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Loading Peer Comparison
Finding companies in the Pharmacy Retail sector...
Financial Statements
Comprehensive financial data for Medplus Health Services Ltd
About MEDPLUS
Business Overview
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soaps, detergents, and sanitizers. The company also engages in wholesale cash and carry; provision of diagnostic, pathological, and laboratory testing services, as well as contract manufacturing of private-label pharmaceuticals, wellness products, and FMCG goods; and operates diagnostic centres. It distributes its products through retail and online channels. The company was incorporated in 2006 and is based in Hyderabad, India.
Company Details
Key Leadership
MEDPLUS Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Medplus Health Services Ltd (MEDPLUS)?
As of 15 Jan 2026, 05:03 am IST, Medplus Health Services Ltd (MEDPLUS) is currently trading at ₹835.85. The stock has a market capitalization of ₹9.71K (Cr).
Is MEDPLUS share price Overvalued or Undervalued?
MEDPLUS is currently trading at a P/E ratio of 49.79x, compared to the industry average of 45.55x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the Medplus Health Services Ltd share price?
Key factors influencing MEDPLUS's price include its quarterly earnings growth (Sales Growth: 6.54%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Medplus Health Services Ltd a good stock for long-term investment?
Medplus Health Services Ltd shows a 5-year Profit Growth of 131.42% and an ROE of 8.80%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.65 before investing.
How does Medplus Health Services Ltd compare with its industry peers?
Medplus Health Services Ltd competes with major peers in the Pharmacy Retail. Investors should compare MEDPLUS's P/E of 49.79x and ROE of 8.80% against the industry averages to determine its competitive standing.
What is the P/E ratio of MEDPLUS and what does it mean?
MEDPLUS has a P/E ratio of 49.79x compared to the industry average of 45.55x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹50 for every ₹1 of annual earnings.
How is MEDPLUS performing according to Bull Run's analysis?
MEDPLUS has a Bull Run fundamental score of 30.9/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does MEDPLUS belong to?
MEDPLUS operates in the Pharmacy Retail industry. This classification helps understand the competitive landscape and sector-specific trends affecting Medplus Health Services Ltd.
What is Return on Equity (ROE) and why is it important for MEDPLUS?
MEDPLUS has an ROE of 8.80%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Medplus Health Services Ltd generates profits from shareholders' equity.
How is MEDPLUS's debt-to-equity ratio and what does it indicate?
MEDPLUS has a debt-to-equity ratio of 0.65, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.
What is MEDPLUS's dividend yield and is it a good dividend stock?
MEDPLUS offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has MEDPLUS grown over the past 5 years?
MEDPLUS has achieved 5-year growth rates of: Sales Growth 16.41%, Profit Growth 131.42%, and EPS Growth -35.35%.
What is the promoter holding in MEDPLUS and why does it matter?
Promoters hold 40.29% of MEDPLUS shares, with 59.34% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is MEDPLUS's market capitalization category?
MEDPLUS has a market capitalization of ₹9713 crores, placing it in the Mid-cap category.
How volatile is MEDPLUS stock?
MEDPLUS has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for MEDPLUS?
MEDPLUS has a 52-week high of ₹N/A and low of ₹N/A.
What is MEDPLUS's operating profit margin trend?
MEDPLUS has a 5-year average Operating Profit Margin (OPM) of 6.90%, indicating the company's operational efficiency.
How is MEDPLUS's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 6.54% and YoY Profit Growth of 43.26%.
What is the institutional holding pattern in MEDPLUS?
MEDPLUS has FII holding of 16.53% and DII holding of 26.51%. Significant institutional holding often suggests professional confidence in the stock.